Works matching AU KIM, JIN‐SEOK
Results: 219
Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00375-2
- By:
- Publication type:
- Article
Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0245-1
- By:
- Publication type:
- Article
Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF).
- Published in:
- Journal of Arrhythmia, 2023, v. 39, n. 3, p. 376, doi. 10.1002/joa3.12840
- By:
- Publication type:
- Article
Real‐world data for the use of emicizumab in haemophilia A patients with inhibitors – First nationwide report from Korea.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1163, doi. 10.1111/hae.14819
- By:
- Publication type:
- Article
Clinical characteristics and prognostic factors of acquired haemophilia A in Korea.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e609, doi. 10.1111/hae.14370
- By:
- Publication type:
- Article
Epidemiological Characteristics of Scrub Typhus in Korea, 2009
- Published in:
- Osong Public Health & Research Perspectives, 2010, v. 1, n. 1, p. 55, doi. 10.1016/j.phrp.2010.12.012
- By:
- Publication type:
- Article
Trends in Water- and Foodborne Disease Outbreaks in Korea, 2007–2009
- Published in:
- Osong Public Health & Research Perspectives, 2010, v. 1, n. 1, p. 50, doi. 10.1016/j.phrp.2010.12.011
- By:
- Publication type:
- Article
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e360, doi. 10.1016/j.clml.2023.06.011
- By:
- Publication type:
- Article
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e751, doi. 10.1016/j.clml.2022.04.005
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 545, doi. 10.1016/j.clml.2022.03.011
- By:
- Publication type:
- Article
Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including Bortezomib and Lenalidomide: KMM-166 Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Prospective, Multicenter Phase II Study of Consolidation with Cyclophosphamide, Bortezomib and Dexamethasone (CVD) in Patients with Multiple Myeloma after Autologous Stem Cell Transplantation; The KMM130 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e291, doi. 10.1016/j.clml.2019.09.478
- By:
- Publication type:
- Article
Analysis of Efficacy and Predictive Factors for Treatment Response of Thalidomide-Containing Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Prior Chemotherapy Including Bortezomib and Lenalidomide.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e69, doi. 10.1016/j.clml.2017.03.125
- By:
- Publication type:
- Article
Daratumumab, Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM Based on Prior Lines and Treatment Exposure: POLLUX.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e116, doi. 10.1016/j.clml.2017.03.211
- By:
- Publication type:
- Article
Bortezomib-Melphalan-Prednisone (VMP) Versus MP as Initial Treatment for Very Elderly Patients With Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e70, doi. 10.1016/j.clml.2017.03.126
- By:
- Publication type:
- Article
Phase 2 Study Using Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma; Final Analysis (KMM150).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e73, doi. 10.1016/j.clml.2017.03.133
- By:
- Publication type:
- Article
The Efficacy and Safety of Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma in Real Clinical Practice : A Study of the Korean Multiple Myeloma Working Party (KMMWP).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e74, doi. 10.1016/j.clml.2017.03.135
- By:
- Publication type:
- Article
Clinical Features and Results of Bortezomib-Melphalan-Prednisone (VMP) as Initial Treatment in Elderly Multiple Myeloma Patients Received Lenalidomide with Dexamethasone (Len/Dex): Subgroup Analysis of Lenalidomide Registry from Korean Multiple Myeloma Working Party (KMM151)
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e129, doi. 10.1016/j.clml.2017.03.233
- By:
- Publication type:
- Article
Depth of Response and MRD with Daratumumab Plus Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM: POLLUX.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e17, doi. 10.1016/j.clml.2017.03.029
- By:
- Publication type:
- Article
The outcomes of Korean Patients With Primary Plasma Cell Leukemia: Analysis of Korean Multiple Myeloma Working Party (KMM160).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e38, doi. 10.1016/j.clml.2017.03.067
- By:
- Publication type:
- Article
A prognostic Scoring System for Patients With Multiple Myeloma Who Were Classified Stage II by Revised International Staging System.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e39, doi. 10.1016/j.clml.2017.03.068
- By:
- Publication type:
- Article
Visualization of gaseous and dissolved CO<sub>2</sub> migration in porous media.
- Published in:
- Environmental Earth Sciences, 2018, v. 77, n. 8, p. 1, doi. 10.1007/s12665-018-7484-5
- By:
- Publication type:
- Article
Primary Thyroid Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type: Clinical Manifestation and Outcome of a Rare Disease - Consortium for Improving Survival of Lymphoma Study.
- Published in:
- Acta Haematologica, 2012, v. 127, n. 2, p. 100, doi. 10.1159/000333113
- By:
- Publication type:
- Article
Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry.
- Published in:
- Acta Haematologica, 2009, v. 122, n. 4, p. 200, doi. 10.1159/000253027
- By:
- Publication type:
- Article
Strains related to 'Candidatus Phytoplasma ulmi'- are associated with Chinese Elm yellows in Korea.
- Published in:
- Journal of Plant Pathology, 2021, v. 103, n. 4, p. 1339, doi. 10.1007/s42161-021-00912-3
- By:
- Publication type:
- Article
Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype.
- Published in:
- British Journal of Haematology, 2002, v. 118, n. 4, p. 1128, doi. 10.1046/j.1365-2141.2002.03767.x
- By:
- Publication type:
- Article
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 6, p. 1989, doi. 10.1007/s00277-023-05603-w
- By:
- Publication type:
- Article
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 863, doi. 10.1007/s00277-023-05090-z
- By:
- Publication type:
- Article
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2051, doi. 10.1007/s00277-021-04407-0
- By:
- Publication type:
- Article
Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 9, p. 2149, doi. 10.1007/s00277-020-04043-0
- By:
- Publication type:
- Article
Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 6, p. 889, doi. 10.1007/s00277-011-1401-2
- By:
- Publication type:
- Article
Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
A novel predictive model for late recurrence after catheter ablation for atrial fibrillation using left appendage volume measured by cardiac computed tomography.
- Published in:
- International Journal of Cardiovascular Imaging, 2021, v. 37, n. 6, p. 2063, doi. 10.1007/s10554-021-02169-4
- By:
- Publication type:
- Article
Feasibility of intracardiac echocardiography imaging from the left superior pulmonary vein for left atrial appendage occlusion.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-term clinical outcomes of catheter ablation in patients with atrial fibrillation predisposing to tachycardia-bradycardia syndrome: a long pause predicts implantation of a permanent pacemaker.
- Published in:
- 2018
- By:
- Publication type:
- journal article